Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pinnacle Biologics
>
Patient Kickback Registry
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4754486"]Kickback/Quid Pro Quo Example</p><p>The conclusion of the e-mail is incriminating</p><p>Bradley, were you seeking to compensate a NON-FDA APPROVED APPLICATION with no fiber approval at Cornell? 5k educational grant and a faculty dinner??</p><p><br /></p><p>1 - 2, the FDA is coming for you! 3 - 4, Guillermo will be out the door. 5 - 6 Bob will have more time to pick up chicks. 7 - 8, PDT has become a dollar short and a day late. 9 - 10, PB will have to pay a stiff fine at the end. </p><p><br /></p><p><br /></p><p>Scroll down to read the e-mail (copied from another thread) in its entirety:</p><p><br /></p><p><br /></p><p>"Conclusion</p><p>· I have a significant desire to support your efforts and too increase patient access to this devastating disease</p><p>· The lack of a commercial fiber severely restricts acceptance of PDT in unresectable cholangiocarcinoma in the US market. </p><p>· Support of the program needs to be realistic to the overall impact- hence I would like to discuss the following options.</p><p><br /></p><p>No fiber approval at Cornell before March 1, 2012</p><p>· $5,000 educational grant plus faculty dinner support</p><p><br /></p><p>Fiber officially approval at Cornell before March, 1, 2012</p><p>· $25,000 educational grant plus faculty dinner </p><p>Once we get full approval of the fiber in the US- we would be able to discuss commitments for future programs.</p><p><br /></p><p>I realize you may be disappointed – but the lack of an appropriate device- will significantly diminish the impact of your program. We have very limited resources because of our lack of a fiber- it is truly a “catch 22.”</p><p>_________________________________________________________________________</p><p>From: Brad Herrmann </p><p>Sent: Monday, January 09, 2012 9:06 AM</p><p>To: Michel</p><p>Subject: RE: Interventional Innovations in Digestive Care: Pinnacle Biologics</p><p> </p><p>Dear Dr. K,</p><p><br /></p><p>I thought about this issue all weekend. The primary issues are communication, access to an appropriate fiber and timing. </p><p><br /></p><p>Communication</p><p>· The first I heard of the program was at your fall meeting. </p><p>· However the first time that I had confirmation of the meeting was mid-December at the NYSGE</p><p>· At the NYSGE you communicated your desire for $50,000 grant plus the faculty dinner. </p><p> That type of investment requires budgeting etc… and I did not have any time to create a budget to capture this type of request.</p><p><br /></p><p>Appropriate fiber</p><p>· We do not have an appropriate fiber in the US for Cholangiocarcinoma. </p><p>· Until we do the “impact” of your conference in the US is negated until such a fiber is commercially available.</p><p>· An appropriate fiber could be made commercially available late in 2012 or 2013.</p><p> However the FDA could demand a trial which would indicate a lack of a fiber until 2017 · The same issue is being implemented at your own institution.</p><p> Until resolution on a fiber is reached- most cases cannot be performed.</p><p> Timing</p><p>· Lead time for a $55,000 was not sufficient. </p><p> 2012 budget planning was already complete- I did not understand your financial need.</p><p>· More important- access to the fiber is the most critical piece of the puzzle. </p><p>· Once a catheter becomes available- conference such as the proposed April program will have the value you have described.</p><p><br /></p><p>Conclusion</p><p>· I have a significant desire to support your efforts and too increase patient access to this devastating disease</p><p>· The lack of a commercial fiber severely restricts acceptance of PDT in unresectable cholangiocarcinoma in the US market. </p><p>· Support of the program needs to be realistic to the overall impact- hence I would like to discuss the following options.</p><p><br /></p><p>No fiber approval at Cornell before March 1, 2012</p><p>· $5,000 educational grant plus faculty dinner support</p><p><br /></p><p>Fiber officially approval at Cornell before March, 1, 2012</p><p>· $25,000 educational grant plus faculty dinner </p><p>Once we get full approval of the fiber in the US- we would be able to discuss commitments for future programs.</p><p><br /></p><p>I realize you may be disappointed – but the lack of an appropriate device- will significantly diminish the impact of your program. We have very limited resources because of our lack of a fiber- it is truly a “catch 22.”</p><p><br /></p><p>I am free this afternoon or any time tomorrow to discuss.</p><p> </p><p>Best regards,</p><p>Brad Herrmann</p><p>Vice-President, PDT Business Unit-US </p><p><br /></p><p>PINNACLE BIOLOGICS, INC[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4754486"]Kickback/Quid Pro Quo Example The conclusion of the e-mail is incriminating Bradley, were you seeking to compensate a NON-FDA APPROVED APPLICATION with no fiber approval at Cornell? 5k educational grant and a faculty dinner?? 1 - 2, the FDA is coming for you! 3 - 4, Guillermo will be out the door. 5 - 6 Bob will have more time to pick up chicks. 7 - 8, PDT has become a dollar short and a day late. 9 - 10, PB will have to pay a stiff fine at the end. Scroll down to read the e-mail (copied from another thread) in its entirety: "Conclusion · I have a significant desire to support your efforts and too increase patient access to this devastating disease · The lack of a commercial fiber severely restricts acceptance of PDT in unresectable cholangiocarcinoma in the US market. · Support of the program needs to be realistic to the overall impact- hence I would like to discuss the following options. No fiber approval at Cornell before March 1, 2012 · $5,000 educational grant plus faculty dinner support Fiber officially approval at Cornell before March, 1, 2012 · $25,000 educational grant plus faculty dinner Once we get full approval of the fiber in the US- we would be able to discuss commitments for future programs. I realize you may be disappointed – but the lack of an appropriate device- will significantly diminish the impact of your program. We have very limited resources because of our lack of a fiber- it is truly a “catch 22.” _________________________________________________________________________ From: Brad Herrmann Sent: Monday, January 09, 2012 9:06 AM To: Michel Subject: RE: Interventional Innovations in Digestive Care: Pinnacle Biologics Dear Dr. K, I thought about this issue all weekend. The primary issues are communication, access to an appropriate fiber and timing. Communication · The first I heard of the program was at your fall meeting. · However the first time that I had confirmation of the meeting was mid-December at the NYSGE · At the NYSGE you communicated your desire for $50,000 grant plus the faculty dinner. That type of investment requires budgeting etc… and I did not have any time to create a budget to capture this type of request. Appropriate fiber · We do not have an appropriate fiber in the US for Cholangiocarcinoma. · Until we do the “impact” of your conference in the US is negated until such a fiber is commercially available. · An appropriate fiber could be made commercially available late in 2012 or 2013. However the FDA could demand a trial which would indicate a lack of a fiber until 2017 · The same issue is being implemented at your own institution. Until resolution on a fiber is reached- most cases cannot be performed. Timing · Lead time for a $55,000 was not sufficient. 2012 budget planning was already complete- I did not understand your financial need. · More important- access to the fiber is the most critical piece of the puzzle. · Once a catheter becomes available- conference such as the proposed April program will have the value you have described. Conclusion · I have a significant desire to support your efforts and too increase patient access to this devastating disease · The lack of a commercial fiber severely restricts acceptance of PDT in unresectable cholangiocarcinoma in the US market. · Support of the program needs to be realistic to the overall impact- hence I would like to discuss the following options. No fiber approval at Cornell before March 1, 2012 · $5,000 educational grant plus faculty dinner support Fiber officially approval at Cornell before March, 1, 2012 · $25,000 educational grant plus faculty dinner Once we get full approval of the fiber in the US- we would be able to discuss commitments for future programs. I realize you may be disappointed – but the lack of an appropriate device- will significantly diminish the impact of your program. We have very limited resources because of our lack of a fiber- it is truly a “catch 22.” I am free this afternoon or any time tomorrow to discuss. Best regards, Brad Herrmann Vice-President, PDT Business Unit-US PINNACLE BIOLOGICS, INC[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pinnacle Biologics
>
Patient Kickback Registry
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Pinnacle Biologics
>
Patient Kickback Registry
>